About TriOptoTec

DYPHOX is a permanently active antimicrobial drug system based on photodynamics. The manufacturer is TriOptoTec GmbH, a spin-off of the University Hospital Regensburg. When a surface is coated with DYPHOX, a thin layer of reactive oxygen is formed on it by the energy of the room light. This reactive oxygen remains in the range of about one millimeter above the surface and destroys all microorganisms there.

This purely physical process is completely harmless to humans.

The DYPHOX coating can be applied subsequently and remains effective for up to one year.

This permanent antimicrobial effect on surfaces of any kind permanently closes hygiene gaps and significantly reduces the risk of passing on germs.

Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.

Facts about TriOptoTec
  • Founding: 2017
  • Focus : Manufacturer
  • Employees: 1-10
  • Industry : Biotechnology

Here you will find TriOptoTec GmbH